期刊文献+

5-FU变形脂质体工艺的改进及其体外透瘢痕的实验研究 被引量:4

Optimization of 5-FU deformable liposomes and experiements with their scar penetration in vitro
下载PDF
导出
摘要 目的通过改进5-氟尿嘧啶(5-FU)变形脂质体的工艺,提高其包封率,探索体外渗透治疗瘢痕的有效方法。方法采用薄膜水化法制备5-FU变形脂质体,利用正交实验探索最佳工艺,检测脂质体的形态、粒径分布、包封率等特性。采用改良Franz扩散池,将改进的5-FU变形脂质体进行体外透瘢痕实验后,行瘢痕切片制备和荧光观察。结果各因素对包封率影响大小的顺序:去氧胆酸钠>5-FU>卵磷脂>超声时间>乳化时间,制备的脂质体为圆球形,粒径均匀,平均粒径为(90±5)nm,包封率达82.14%。体外透瘢痕实验5-FU累积透过量低于5%,滞留于瘢痕内的5-FU累积量高达45%,主要集中在瘢痕的表皮层和真皮浅层。结论改进后的5-FU变形脂质体,其包封率较高、粒径较小且均匀,能渗透到瘢痕的表皮层和真皮浅层。 Objective To improve the encapsulation efficiency of 5 - FU by optimizing the technology of 5 - FU deformable liposomes, and research their scar penetration in vitro. Methods The 5 - FU deformable liposome was prepared by the thin film hydration method, and the optimal method was determined by the orthogonal test. The amorphous, size distribution and the encapsulation efficiency of the 5 - FU deformable liposome were investigated. Their scar penetration in vitro was evaluated with the improved Franz diffusion cell. Results The effect of factors on the eacapsulation efficiency of the 5 - FU deformable liposome were randed as follow: sodium deoxycholate 〉 5 - FU〉soybean lecithin〉the time of ultra- sound〉the time of emulsification. The liposcomes were spherical vesicles with uniform sizes. The mean diameter of the 5 - FU deformable liposome was (90 ± 5 ) nm. The entrapment efficiency of these 5 - FU liposorne was as high as 82.14 %. In vitro, the accumulated mass of 5 - FU which passed through scar was below 5 %. However, that retained in the scar was 45 %. The deformable liposome mainly concerttrated in the epidermis and the top of the corium as observed by microphotographs by CLSM. Conclusion 5 - FU deformable liposomes with higher encapsulation efficiency and smaller, uniform sizes may be obtained by optimizing the formulation. These liposorne can penetrate the epidermis and the top of the corium of scar.
出处 《中国美容整形外科杂志》 CAS 2008年第2期96-99,共4页 Chinese Journal of Aesthetic and Plastic Surgery
基金 上海市科委基金资助项目(054119527) 上海市教委基金资助项目(05BZ21)
关键词 变形脂质体 正交实验 包封率 透瘢痕实验 5-氟尿嘧啶 Deformable liposome Orthogonal test Encapsulation efficiency Scar penetration experiment 5 - fluorouracil
  • 相关文献

参考文献9

  • 1[1]ELSAYED M M,ABDALLAH O Y,NAGGAR V F,et al.Lipid vesicles for skin delivery of drugs:reviewing three decades of research[J].Int J Pharm,2007,332(1-2):1-16.
  • 2[2]L(O)PEZ-PINTO J M,GONZ(A)LEZ-RODR(I)1GUEZ M L,RABASCO A M.Effect of cholesterol and ethanol on dermal delivery from DPPC liposome[J].Int J Pharm,2005,298(1):1-12.
  • 3[3]MANCONI M,VALENTI D,SINICO C,et al.Niosomes as carriers for tretinoin Ⅱ.Influence of vesicular incorporation on tretinoin photostability[J].Int J Pharm,2003,260(2):261-272.
  • 4[4]DAYAN N,TOUITOU E.Carriers for skin delivery of trihexyphenidyl HCl:ethosomes vs,liposomes[J].Biomaterials,2000,21(18):1879-1885.
  • 5[5]ELSAYED M M,ABDALLAH O Y,NAGGAR V Y,et al.Deformable liposomes and ethosomes:mechanism of enhanced skin delivery[J].Int J Pharm,2006,322(1-2):60-66.
  • 6武晓莉,刘伟,曹谊林.低浓度5-氟尿嘧啶抑制血管增生在瘢痕疙瘩综合治疗中的作用初探[J].中华整形外科杂志,2006,22(1):44-46. 被引量:44
  • 7武晓莉,刘伟,高振,曹谊林.低浓度5-FU与糖皮质激素联合治疗胸骨前瘢痕疙瘩的疗效分析[J].中国美容整形外科杂志,2007,18(6):437-440. 被引量:20
  • 8陈天新,武凤莲,王冬艳,关德宏.5-FU对增生性瘢痕中cyclinD_1、cdk4及p53基因表达的影响[J].中国美容整形外科杂志,2006,17(5):343-346. 被引量:8
  • 9[9]TROTTA M,PEIRA E,CARLOTTI M E,et al.Deformable liposomes for dermal administration of methotrexate[J].Int J Pharm,2004,270(1-2):119-125.

二级参考文献22

  • 1JingYuanFANG YingXuanCHEN JuanLU RongLU LiYANG HongYinZHU WeiQiGU LunGenLU.Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116[J].Cell Research,2004,14(3):217-226. 被引量:46
  • 2于冬梅,陈天新,吕松岑,韩竹.病理性瘢痕中p53和cyclinD_1的mRNA表达的实验研究[J].中国实用美容整形外科杂志,2005,16(2):74-76. 被引量:17
  • 3Urioste SS,Arndt KA,Dover JS.Keloids and hypertrophic scars:review and treatment strategies.Semin Cutan Med Surg,1999,18:159-171.
  • 4Berman B,Bieley HC.Keloids.J Am Acad Dermatol,1995,33:117-123.
  • 5Alster TS,Handrick C.Laser treatnent of hypertrophic scars,keloids,and striae.Semin Cutan Med Surg,2000,19:287-292.
  • 6Fitzpatrick RE.Treatment of inflamed hypertrophic scars using intralesional 5-FU.Dermatol Surg,1999,25:224-232.
  • 7Mustoe TA,Cooter RD,Gold MH,et al.International clinical recommendations on scar management.Plast Reconstr Surg,2002,110:560-571.
  • 8Gupta S,Kalra A.Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids.Dermatology,2002,204:130-132.
  • 9[1]NENDELEC B,SHANKOWSKY H,SCOTT P G,et al.Myofibroblasts and apoptosis in hu-man hypertrophic scars:the effect of interferon-alpha2b[J].Surgery,2001,130(5):798-808.
  • 10[3]FITZPATRICK R E.Treatment of inflamed hypertrophic scar using intralesional 5-FU[J].Dermator Surg,1999,25(3):224-232.

共引文献60

同被引文献56

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部